FDA Updates Darolutamide Label for Prostate Cancer

[-G-]

So I have been watching or rather, set a google alert for "androgen inhibitor", and occasionally come across interesting articles mainly in the prostate cancer field.

IF I am not mistaken, Kintor is doing something similar? Could this perhaps be a change?

FDA Updates Darolutamide Label for Prostate Cancer

The FDA has approved a supplemental new drug application to add overall survival (OS) and other secondary end point data from the phase 3 ARAMIS trial (NCT02200614) to the prescribing information for darolutamide (Nubeqa) for the treatment of patients with nonmetastatic prostate cancer (nmCRPC).

www.oncnursingnews.com

 

[hemingway_the_mercenary]

This has nothing to do with hairloss really but prostate cancer will have the ultimate treatment within the next 12 years as ARV-330 degrades the AR with potency almost as strong and Testosterone mg per mg meaning it’s far stronger than Daro and everything else out now.

 

[-G-]

This has nothing to do with hairloss really but prostate cancer will have the ultimate treatment within the next 12 years as ARV-330 degrades the AR with potency almost as strong and Testosterone mg per mg meaning it’s far stronger than Daro and everything else out now.

Could this not be used for hair loss if finasteride was originally for prostate cancer too?

 

[AndrewBarnes]

Can someone please find me a link of Darolutamide's mechanism of action, it's effect on testosterone/estrogen, or if it causes gyno. Does it decrease or increase test or E? Can't find anything online.